反应条件
1: 97 percent / 4 N HCl / dioxane / 1 h / Ambient temperature 2: 1.) hydroxybenzotriazole (HOBt), EDCI, 2.) N-methylmorpholine (NMM) / 1.) DMF, 40 min, 2.) DMF, a) 0 deg C, 2 h, b) RT, overnight 3: 4 N HCl / dioxane / 1 h / Ambient temperature 4: 1.) hydroxybenzotriazole (HOBt), EDCI, 2.) N-methylmorpholine (NMM) / 1.) DMF, 40 min, 2.) DMF, a) 0 deg C, 2 h, b) RT, overnight 5: 4 N HCl / dioxane / 1 h / Ambient temperature 6: 1.) hydroxybenzotriazole (HOBt), EDCI, 2.) N-methylmorpholine (NMM) / 1.) DMF, 40 min, 2.) DMF, a) 0 deg C, 2 h, b) RT, overnight 7: 4 N HCl / dioxane / 1 h / Ambient temperature 8: triethylamine, DCM / dimethylformamide / 2 h / 0 - 20 °C 9: NaI, NaHCO3 / dimethylformamide / 18 h / Ambient temperature 10: NaBH4 / methanol 11: 99 percent / H2 / 10percent Pd(OH)2/C / aq. acetic acid / 4 h View Scheme
参考文献
Rich; Vara Prasad; Sun; Green; Mueller; Houseman; MacKenzie; Malkovsky
Journal of Medicinal Chemistry, 1992 , vol. 35, # 21 p. 3803 - 3812